"Ginger wants everyone to know that strength and positivity will prevail" ...

LONDON, England — Ginger Wildheart, the frontman and founding member of British rock band The Wildhearts, has been diagnosed ...

A rockstar who previously survived severe mental health battles is refusing cancer treatment, leaving them with ‘2-3 years’ ...

THE frontman of a British rock band has vowed to press ahead with their upcoming tour – despite being diagnosed with a rare ...

A BRITISH rock star has revealed he’s refused cancer treatment and has “2-3 years left” to say goodbye to everyone.

British rock band The Wildhearts announced this week that its frontman and founding member, Ginger Wildheart, has been diagnosed with Mantle Cell Lymphoma, a rare but aggressive form of cancer. The ...

Ginger Wildheart, who is refusing treatment, says he "has lived the life of 10 men".

At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 inhibitor in heavily pretreated, largely refractory mantle cell lymphoma. At ASH ...

• BTK inhibitors work by targeting and blocking the BTK enzyme, which is crucial for the survival and growth of cancerous B-cells in mantle cell lymphoma (MCL). This cuts off the cancer cell’s support ...

Translocations are chromosomal "cut and paste" errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but ...

• BTK inhibitors are a type of targeted therapy for mantle cell lymphoma that works by blocking a specific enzyme, BTK, which is crucial for the cancer cells’ survival and spread. This interference ...